US 10836744
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
granted A61KA61K31/444A61K31/4709
Quick answer
US patent 10836744 (Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity) held by Theravance Respiratory Company, LLC expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Respiratory Company, LLC
- Grant date
- Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/444, A61K31/4709, A61K31/56, A61K45/06